These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 20425679

  • 1. [New, expensive antidiabetics for the treatment of type-2 diabetes--contra].
    Nawroth P.
    Dtsch Med Wochenschr; 2010 May; 135(18):923. PubMed ID: 20425679
    [No Abstract] [Full Text] [Related]

  • 2. [New, expensive antidiabetics for the treatment of type-2 diabetes--pro].
    Müller-Wieland D.
    Dtsch Med Wochenschr; 2010 May; 135(18):922. PubMed ID: 20425678
    [No Abstract] [Full Text] [Related]

  • 3. [Obesity and diabetes mellitus: increasing problems call for increasing efforts].
    Nauck M.
    Dtsch Med Wochenschr; 2010 May; 135(18):901. PubMed ID: 20425673
    [No Abstract] [Full Text] [Related]

  • 4. [How AMOG limits the supply of diabetes drugs].
    Oberhofer E.
    MMW Fortschr Med; 2015 Aug 20; 157(14):24. PubMed ID: 26289868
    [No Abstract] [Full Text] [Related]

  • 5. [Disease management programs: data for the waste bin?].
    Martin S.
    Dtsch Med Wochenschr; 2014 Jan 20; 139(1-2):17-8. PubMed ID: 24062020
    [No Abstract] [Full Text] [Related]

  • 6. [Cost saving program instead of optimizing therapy: disease mismanagement in diabetes mellitus? (interview by Dr. med. Jochen Aumiller)].
    Rett K.
    MMW Fortschr Med; 2005 Jun 02; 147(22):15. PubMed ID: 15977626
    [No Abstract] [Full Text] [Related]

  • 7. [Human insulin vs. analogs. What is the cost of supplementary insulin therapy?].
    Lundershausen R, Potthoff F, Häuser C, Kaiser M, Münscher C.
    MMW Fortschr Med; 2006 Nov 09; 148(45):42. PubMed ID: 17615748
    [No Abstract] [Full Text] [Related]

  • 8. [Assessment of novel antidiabetic drugs in Germany. Do innovations still have a chance?].
    Gallwitz B.
    MMW Fortschr Med; 2014 Jul 24; 156(13):57-60. PubMed ID: 25318228
    [No Abstract] [Full Text] [Related]

  • 9. Liraglutide vs. sitagliptin add-on to metformin treatment for type 2 diabetes mellitus: Short-term cost-per-controlled patient in Italy.
    Ferrario MG, Lizán L, Montagnoli R, Ramírez de Arellano A.
    Prim Care Diabetes; 2016 Jun 24; 10(3):220-6. PubMed ID: 26546244
    [Abstract] [Full Text] [Related]

  • 10. [The German diabetes dilemma: DMP: insufficient management of the diabetic patient in general practice?].
    MMW Fortschr Med; 2005 Oct 13; 147(41):10. PubMed ID: 16270503
    [No Abstract] [Full Text] [Related]

  • 11. [Hypoglycemia--simply annoying or dangerous?].
    Kern W.
    MMW Fortschr Med; 2016 Jun 09; 158(11):67-70. PubMed ID: 27271419
    [No Abstract] [Full Text] [Related]

  • 12. Empagliflozin/metformin (Synjardy) for type 2 diabetes.
    Med Lett Drugs Ther; 2015 Dec 21; 57(1484):172-4. PubMed ID: 26670554
    [No Abstract] [Full Text] [Related]

  • 13. [Typ 2 diabetes: glucose centered therapy is obsolete].
    Reincke M, Seissler J.
    MMW Fortschr Med; 2008 May 01; 150(18):26-7. PubMed ID: 18533604
    [No Abstract] [Full Text] [Related]

  • 14. Medical resource use, disturbance of daily life and burden of hypoglycemia in insulin-treated patients with diabetes: results from a European online survey.
    Willis WD, Diago-Cabezudo JI, Madec-Hily A, Aslam A.
    Expert Rev Pharmacoecon Outcomes Res; 2013 Feb 01; 13(1):123-30. PubMed ID: 23402452
    [Abstract] [Full Text] [Related]

  • 15. [Increased risk of hypoglycemia in the elderly and frail. Steep decrease of HbA1c is not always advisable].
    Pampel SL.
    MMW Fortschr Med; 2011 Jul 21; 153(29-31):20. PubMed ID: 21830731
    [No Abstract] [Full Text] [Related]

  • 16. [Questions for practicing internists].
    Zinnenlauf S.
    Praxis (Bern 1994); 2008 Aug 27; 97(17):945-6. PubMed ID: 18777778
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Costs involved in the early and late phases of diabetes mellitus].
    Liebl A.
    Internist (Berl); 2007 Jul 27; 48(7):708-14. PubMed ID: 17576527
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Medication prices in Germany--how are they determined?].
    Bruhn C.
    Dtsch Med Wochenschr; 2010 Oct 27; 135(39):p34. PubMed ID: 20922657
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.